BF Biosciences Limited (PSX:BFBIO)
Pakistan · Delayed Price · Currency is PKR 153.75
+0.77 (0.50%)
At close: Nov 28, 2025
BF Biosciences Cash Flow Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2019 - 2020 |
Net Income | 491.4 | 447.15 | 385.41 | 149.05 | 306.98 | 607.99 | Upgrade |
Depreciation & Amortization | 243.56 | 191.92 | 35.57 | 33.78 | 28 | 23 | Upgrade |
Other Amortization | 1.98 | 1.69 | 0.55 | 0.55 | - | - | Upgrade |
Loss (Gain) From Sale of Assets | -2.8 | -2.79 | -2.13 | -1.06 | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -58.12 | -27.3 | -0.21 | -8.93 | - | - | Upgrade |
Other Operating Activities | 15.35 | 44.33 | 305.49 | 32.12 | -156.98 | -60.99 | Upgrade |
Change in Accounts Receivable | -96.24 | 20.37 | -110.82 | -41.1 | - | - | Upgrade |
Change in Inventory | -653.66 | -846.4 | -41.57 | -445.69 | - | - | Upgrade |
Change in Accounts Payable | 271.82 | 472.43 | 196.75 | -5.94 | - | - | Upgrade |
Change in Unearned Revenue | -5.99 | -5.27 | 19.75 | -17.78 | - | - | Upgrade |
Change in Other Net Operating Assets | 83.78 | 3.66 | -124.09 | 108.94 | - | - | Upgrade |
Operating Cash Flow | 291.08 | 299.79 | 664.7 | -196.07 | 178 | 570 | Upgrade |
Operating Cash Flow Growth | -38.38% | -54.90% | - | - | -68.77% | - | Upgrade |
Capital Expenditures | -296.52 | -329.49 | -143.13 | -1,968 | -1,130 | -941 | Upgrade |
Sale of Property, Plant & Equipment | 3.87 | 3.86 | 4.4 | 1.06 | - | - | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | -1.66 | - | - | Upgrade |
Investment in Securities | -1,200 | -1,100 | 108.58 | 1,161 | - | - | Upgrade |
Other Investing Activities | 95.27 | 91 | 16.34 | 83.4 | -333 | -399 | Upgrade |
Investing Cash Flow | -1,397 | -1,335 | -13.81 | -724.44 | -1,463 | -1,340 | Upgrade |
Long-Term Debt Issued | - | 93.55 | - | 811.02 | - | - | Upgrade |
Long-Term Debt Repaid | - | -436.19 | -321.36 | -50.5 | - | - | Upgrade |
Net Debt Issued (Repaid) | -379.42 | -342.64 | -321.36 | 760.52 | - | - | Upgrade |
Issuance of Common Stock | 203.2 | 1,855 | - | - | - | - | Upgrade |
Other Financing Activities | -108.89 | -112.25 | -161.52 | -120.28 | 925 | 1,162 | Upgrade |
Financing Cash Flow | -285.11 | 1,400 | -482.88 | 640.24 | 925 | 1,162 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 1 | 1 | Upgrade |
Net Cash Flow | -1,391 | 365.04 | 168.02 | -280.27 | -359 | 393 | Upgrade |
Free Cash Flow | -5.44 | -29.71 | 521.57 | -2,164 | -952 | -371 | Upgrade |
Free Cash Flow Margin | -0.08% | -0.51% | 14.26% | -119.61% | -62.60% | -21.14% | Upgrade |
Free Cash Flow Per Share | -0.06 | -0.37 | 8.23 | -34.17 | -15.03 | -5.86 | Upgrade |
Cash Interest Paid | 108.89 | 112.25 | 161.52 | 120.28 | - | - | Upgrade |
Cash Income Tax Paid | 347.15 | 279.05 | 51.39 | 73.4 | - | - | Upgrade |
Levered Free Cash Flow | -2,130 | -255.5 | 313.25 | -2,306 | -834 | -670.45 | Upgrade |
Unlevered Free Cash Flow | -2,064 | -183.39 | 401.52 | -2,306 | -792.99 | -654.66 | Upgrade |
Change in Working Capital | -400.29 | -355.21 | -59.98 | -401.58 | - | - | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.